Product category:
Genomics
News Release from: Transgenomic | Subject: Wave
Edited by the Laboratorytalk Editorial
Team on 14 January 2002
Old records meet new Wave
Old church records and Transgenomic's Wave nucleic acid fragment analysis system are being brought together in the north of Sweden to investigate a variety of familial diseases
According to Urban Hellman, research engineer in medical genetics at Umea University, "This research is possible because the Swedish church has records dating back to the sixteenth century and because northern Sweden has been quite isolated up until the last century In addition, in Umea we have a blood bank of samples from the local population available for approved research projects." The Wave system uses a highly sensitive HPLC method to detect the presence of mutations
This article was originally published on Laboratorytalk on 7 Mar 2002 at 8.00am (UK)
Related stories
Helping osteoporosis research in Sweden
Researchers are using a nucleic acid fragment analysis system to identify novel genetic polymorphisms linked to osteoporosis and cardiovascular disease
Receptor mutations in clinical specimens
Nuclease used to detect mutations associated with response to therapy in lung cancer; high-sensitivity scanning for epidermal growth factor
A DNA sample is hybridised with a reference DNA, and if a mutation is present the temperature at which the two strands separate is lowered.
The Wave system provides a rapid and automated way of measuring this temperature change.
Urban Hellman was clear about the reasons for his group's choice of the Transgenomic system: "The Wave system is the only way to search for unknown mutations with any degree of high throughput and there just wasn't anything else on the market that suited our specifications.
We use the system clinically to look for one transthyretin related amyloidosis, cystic fibrosis, and colon cancer.
On the research side the applications are increasing all the time.
We are looking for loss of heterozygosity and mutations in a whole range of diseases - stroke, migraine, breast cancer, hypertrophic cardiomyopathy, retinitis pigmentosa, multiple sclerosis, and focal non-epidermolytic palmoplantar keratoderma ....
so far!".
• Transgenomic: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
